Details of the Drug Formulations

General Information of Drug (ID: DMSQ8MD)

• Drug Name: Anagrelide Drug Info
• Synonyms: Anagrelida; Anagrelidum; BL 416201; Agrylin (TN); Anagrelida [INN-Spanish]; Anagrelide [BAN:INN]; Anagrelide [INN:BAN]; Anagrelidum [INN-Latin]; Xagrid (TN); Anagrelide (INN/BAN); 6,7-Dichlor-1,5-dihydroimidazo(2,1-b)chinazolin-2(3H)-on; 6,7-Dichloro-1,5-dihydroimidazo(2,1-b)quinazolin-2(3H)-one; 6,7-dichloro-1,5-dihydroimidazo[2,1-]quinazolin-2(3H)-one; 6,7-dichloro-5,10-dihydro-3H-imidazo[2,1-b]quinazolin-2-one

Indication

Disease Entry	ICD 11	Status	REF
Thrombocythemia	3B63	Approved	[1]
Essential thrombocythemia	3B63.1Z	Phase 2	[2]

• Therapeutic Class: Antithrombotic Agents
• Cross-matching ID:
  PubChem CID: 135409400
  ChEBI ID: CHEBI:142290
  CAS Number: 68475-42-3
  TTD ID: D0D1HW
  INTEDE ID: DR0112
  ACDINA ID: D00038

Full List of Drug Formulations Containing This Drug

Anagrelide 0.5 mg capsule

Company	Formulation ID	FDA Description
Mylan Pharamceuticals	F01330	Anhydrous lactose; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Crospovidone; Povidone; Cellulose, microcrystalline; Gelatin; Shellac
Avera McKennan Hospital; Carilion Materials Management	F01334	Anhydrous lactose; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Crospovidone; Povidone k30; Aluminum oxide; Cellulose, microcrystalline; Gelatin; Shellac
Physicians Total Care	F01332	Anhydrous lactose; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Crospovidone; Povidone; Aluminum oxide; Cellulose, microcrystalline; Gelatin
Teva Pharmaceuticals	F01333	Anhydrous lactose; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Povidone k30; Cellulose, microcrystalline; Crospovidone (15 mpa.s at 5%); Gelatin; Shellac
Torrent Pharmaceuticals	F01329	Lactose monohydrate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin; Hydroxypropyl cellulose (type h); Shellac
Shire	F01331	Anhydrous lactose; Lactose monohydrate; Magnesium stearate; Povidone k30; Crospovidone, unspecified; Microcrystalline cellulose

Anagrelide 1 mg capsule

Company	Formulation ID	FDA Description
Mylan Pharamceuticals	F01336	Anhydrous lactose; Sodium lauryl sulfate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Crospovidone; Povidone; Cellulose, microcrystalline; Gelatin; Shellac
Teva Pharmaceuticals	F01337	Anhydrous lactose; Lactose monohydrate; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Povidone k30; Cellulose, microcrystalline; Crospovidone (15 mpa.s at 5%); Gelatin; Shellac
Torrent Pharmaceuticals	F01335	Lactose monohydrate; Magnesium stearate; Ferrosoferric oxide; Potassium hydroxide; Propylene glycol; Titanium dioxide; Croscarmellose sodium; Cellulose, microcrystalline; Gelatin; Hydroxypropyl cellulose (type h); Shellac

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7114).
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)